Hyperinsulinism as a common cause of hypoglycemia in children - Pathogenesis, diagnosis and treatment

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 19, Issue 1, 2013, Pages 24-28

  Buraczewska, Marta ^a   Kopacz, Katarzyna ^a   Myśliwiec, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Congenital hyperinsulinism; Hypoglycemia; Molecular mechanisms

Indexed keywords

AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; AMMONIA BLOOD LEVEL; GENETIC SCREENING; GROWTH HORMONE BLOOD LEVEL; HEPATOMEGALY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINISM; HYPERPIGMENTATION; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULINOMA; LACTATE BLOOD LEVEL; LIVER FAILURE; MATERNAL DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; REVIEW; SEPTICEMIA; BLOOD; CHEMICALLY INDUCED; CHILD; CHILD WELFARE; CLASSIFICATION; COMPLICATION; FEMALE; HEALTH STATUS; MALE;

ANTIDIABETIC AGENT; AUTOANTIBODY; INSULIN; INSULIN ANTIBODY;

AUTOANTIBODIES; CHILD; CHILD WELFARE; FEMALE; HEALTH STATUS; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ANTIBODIES; MALE;

EID: 84897363598     PISSN: None     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Zatońska K, Bolanowski M. Hypoglycemia as a diagnostic problem. Adv Clin Exp Med. 2003;12;369-373.
2. McCrimmon RJ. Update in the CNS response to hypoglycemia. J Clin Endocrinol Metab. 2012;97:1-8.
3. Tesfaye N, Seaquist ER. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci. 2010;1212:12-28.
4. nd edition. Friedrichsdorf: Milupa; 2004.
5. Das CJ, Debnath J, Gupta AK, Das AK. MR imaging appearance of insulinoma in an infant. Pediatr Radiol. 2007;37:581-583.
6. Janem W, Sultan I, Ajlouni F, et al. Malignant insulinoma in a child. Pediatr Blood Cancer. 2010;55:1423-1426.
7. Wouter W, van Schaik E, Kwekkeboom D, Feelders RA., New therapeutic options for metastatic malignant insulinomas, Clin Endocrinol. 2011;75:277-284.
8. Wolfsdorf, Senior B. The diagnosis of insulinoma in a child in the absence of fasting hyperinsulinemia. Pediatrics. 1979;64:496-498.
9. Cavaco B, Uchigata Y, Porto T, et al. Hypoglycaemia due to insulin autoimmune syndrome: report of two cases with characterisation of HLA alleles and insulin autoantibodies. Eur J Endocrinol. 2001;145:311-316.
10. Archambeaud-Mouveroux F, Huc MC, Nadalon S, et al. Autoimmune insulin syndrome. Biomed Pharmacother. 1989;43:581-586.
11. Lupsa BC, Chong AY, Cochran EK, et al., Autoimmune forms of hypoglycemia. Medicine (Baltimore). 2009;88:141-153.
12. Ouyang D, Dhall D, Yu R. Pathologic pancreatic endocrine cell hyperplasia. World J Gastroenterol. 2011;17:137-143.
13. Palladino A, Stanley CA. Nesidioblastosis no longer! It's all about genetics. J Clin Endocrinol Metab. 2011;96:617-619.
14. Arnoux JB, Verkarre V, Saint-Martin C, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orph J Rare Diseas. 2011;6:63.
15. Kopieczna-Grzebieniak E, Kotrys-Puchalska E. Heterogeneity and treatment of congenital hyperinsulinism. Przegl Pediatr. 2004;34:84-93.
16. Mysliwiec M. Modulators of K+ channels in diabetology. In: Kocic I. Potassium channels as a target for clinical therapeutics. Sharjah: Bentham Science Publishers, 2012. p.40-61.
17. Pinney SE, MacMullen C, Becker S. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest. 2008;118:2877-2886.
18. Palladino AA, Bennett MJ, Stanley CA. Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem. 2008;54: 256-263.
19. Giurgea I, Bellanné-Chantelot C, Ribeiro M, et al. Molecular mechanisms of neonatal hyperinsulinism. Horm Res. 2006;66:289-296.
20. Kurmaran A, Kar S, Kapoor RR, Hussain K. The clinical problem of hyperinsulinemic hypoglycemia and resultant infantile spasms. Pediatrics. 2010;126;1231-1236.
21. Macmullen CM, Zhou Q, Snider KE, et al., Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. Diabetes. 2011;60:1797-1804.
22. Saint-Martin C, Arnoux JB, de Lonlay P, Bellanné-Chantelot C. KATP channel mutations in congenital hyperinsulinism. Semin Pediatr Surg. 2011;20:18-22.
23. Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353:249-254.
24. Witteles RM, Straus II FH, Sugg SL, et al., Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma. Arch Surg. 2001;136:656-663.
25. Cui Y, Elahi D, Andersen DK. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg. 2011;10:1879-1888.
26. Kauhanen S, Seppänen M, Minn H, Nuutila P. Clinical PET imaging of insulinoma and beta-cell hyperplasia. Curr Pharm Des. 2010;14:1550-1560.
27. Douillard C, Mention K, Dobbelaere D, et al. Hypoglycaemia related to inherited metabolic diseases in adults. Orph J Rare Diseas. 2012;7:26.
28. Russo C, Salina A, Aloi C, et al. Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching insulin to sulfonylurea. Diabetes Res Clin Pract. 2011;94:e50-52.
29. Søvik O, Aagenaes O, Eide SA, et al. Familial occurence of neonatal diabetes with duplications in chromosome 6q24: treatment with sulfonylurea and 40-yr follow up. Pediatr Diabetes. 2012;13:155-162.